Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE0000003X8

Price
2.76 USD
Market cap
1.47 bn USD
P/E (2025)
38.56
P/S (2025)
0.76
Dividend yield
2.47 %
Net margin
1.96 %
Return on equity (ROE)
1.60 %
Return on assets (ROA)
1.22 %

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B financials

Fiscal year20242025
Revenue2.05 bn CNY1.95 bn CNY
Gross profit973.74 m CNY880.69 m CNY
Operating income134.38 m CNY110.77 m CNY
EBIT100.37 m CNY80.94 m CNY
Net income71.39 m CNY38.24 m CNY
Diluted EPS – continuing operations0.13 CNY0.07 CNY

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and bones series; and magical doll medicine series. It also provides toothache relief drops; parsnicillin tablets, compound amino acid vitamin capsules, compound chlorhexidine dexamethasone, nasal and mouth cleansing spray, constipation relief capsules, anwei tablets, motherwort paste, gynecological menstrual regulating tablets, Sangju cold tablets, hawthorn granules, isatis root granules, col and cough syrup, and gastritis relief granules, as well as acetaminophen, caffeine, and flavoxate tablets. The companys products are used for therapeutic areas such as anti-tumor, cold and cough relief, cardiovascular and cerebrovascular diseases, rheumatic bone pain, antifungal, tonifying and calming mind, and gynecological diseases. In addition, it is involved in wholesale and retail trade, and culture and art businesses; provision of software and information technology services. It also exports its products. The company was founded in 1992 and is based in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.